Dr Obinna Ubah | The University of Aberdeen

Dr Obinna Ubah

BPharm., MSc., PhD., PGCert(IP Law), AFHEA

Honorary Lecturer

About

Email Address: obinna.ubah@abdn.ac.uk
Telephone Number: +44 (0)1224 438574
Office Address: Liberty Building, Room 22b
School/Department: School of Medicine, Medical Sciences and Nutrition

Publications

Page 1 of 1 Results 1 to 3 of 3

Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography
2021 - Published
Ubah, O. C., Lake, E. W., Gunaratne, G. S., Gallant, J. P., Fernie, M., Robertson, A. J., Marchant, J. S., Bold, T. D., Langlois, R. A., Matchett, W. E., Thiede, J. M., Shi, K., Yin, L., Moeller, N. H., Banerjee, S., Ferguson, L., Kovaleva, M., Porter, A. J., Aihara, H., LeBeau, A. M., Barelle, C. J.
Nature Communications, vol. 12, no. 1, 7325
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.1038/s41467-021-27611-y
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/17761/1/Ubah_etal_NC_Mechanisms_Of_Sars_VoR.pdf
In Vitro ELISA and Cell-Based Assays Confirm the Low Immunogenicity of VNAR Therapeutic Constructs in a Mouse Model of Human RA: An Encouraging Milestone to Further Clinical Drug Development
2020 - Published
Ubah, O., Porter, A. J., Barelle, C. J.
Journal of Immunology Research, vol. 2020, pp. 7283239
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.1155/2020/7283239
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/13655/1/Ubah_etal_JImmRes_Invitro_VOR.pdf
- [ONLINE] View publication in Scopus
Uveitis Therapy With Shark Variable Novel Antigen Receptor Domains Targeting Tumor Necrosis Factor Alpha or Inducible T-Cell Costimulatory Ligand
2019 - Published
Pepple, K. L., Wilson, L., Van Gelder, R. N., Kovaleva, M., Ubah, O. C., Steven, J., Barelle, C. J., Porter, A.
Translational vision science & technology, vol. 8, no. 5, 11
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.1167/tvst.8.5.11
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/12970/1/Uveitis_therapy_TVST_Pepple_et_al_VoR.pdf
- [ONLINE] View publication in Scopus

Update

Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography

In Vitro ELISA and Cell-Based Assays Confirm the Low Immunogenicity of VNAR Therapeutic Constructs in a Mouse Model of Human RA: An Encouraging Milestone to Further Clinical Drug Development

Uveitis Therapy With Shark Variable Novel Antigen Receptor Domains Targeting Tumor Necrosis Factor Alpha or Inducible T-Cell Costimulatory Ligand